Literature DB >> 24560692

Persistent lone atrial fibrillation: clinicopathologic study of 19 cases.

Domenico Corradi1, Sergio Callegari2, Laura Manotti3, David Ferrara4, Matteo Goldoni5, Rossella Alinovi5, Silvana Pinelli5, Paola Mozzoni6, Roberta Andreoli6, Angeliki Asimaki7, Alberto Pozzoli4, Gabriella Becchi3, Antonio Mutti5, Stefano Benussi4, Jeffrey E Saffitz7, Ottavio Alfieri4.   

Abstract

BACKGROUND: The extent to which atrial myocardium is remodeled in patients with persistent lone atrial fibrillation (LAF) is largely unknown.
OBJECTIVE: The purpose of this study was to perform a clinicopathologic investigation in patients with persistent LAF.
METHODS: We characterized structural and molecular remodeling in atrial biopsies from 19 patients (17 males, mean age 49 years) with persistent (>7 days; n = 8) or long-lasting persistent (>1 year; n = 11) LAF who underwent surgical ablation. Atrial tissue from 15 autopsy samples without clinicopathologic evidence of heart disease served as controls.
RESULTS: Morphometric analysis showed cardiomyocyte hypertrophy and greater amounts of myolytic damage and interstitial fibrosis in persistent LAF patients compared to controls (P <.0001). Atrial tissue levels of heme oxygenase-1 and 3-nitrotyrosine were increased in persistent LAF patients (P <.001), consistent with oxidative stress. Levels of superoxide dismutase-2, interleukin-8, interleukin-10, tumor necrosis factor-α, and thiobarbituric acid reactive substance were greater in controls than in persistent LAF patients. Immunoreactive signal for connexin43 was reduced more frequently in persistent LAF patients than controls. There was no correlation between features of structural or molecular remodeling and clinical parameters, including persistent LAF duration.
CONCLUSION: In persistent LAF patients, the atria are modified by structural remodeling and molecular changes of oxidative stress. Tissue changes in persistent LAF appear to occur early after its onset and are qualitatively no different than those observed in patients with atrial fibrillation related to conventional risk factors. These findings suggest that different types of atrial fibrillation are associated with the same spectrum of tissue lesions. Early intervention to restore sinus rhythm in persistent LAF patients may prevent irreversible tissue change, especially interstitial fibrosis.
Copyright © 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial cardiomyocyte; Lone atrial fibrillation; Pathology; Remodeling; Structure

Mesh:

Substances:

Year:  2014        PMID: 24560692     DOI: 10.1016/j.hrthm.2014.02.008

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  20 in total

Review 1.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

Review 2.  Inflammation and the pathogenesis of atrial fibrillation.

Authors:  Yu-Feng Hu; Yi-Jen Chen; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Nat Rev Cardiol       Date:  2015-01-27       Impact factor: 32.419

Review 3.  Left atrial appendage exclusion for atrial fibrillation.

Authors:  Faisal F Syed; Christopher V DeSimone; Paul A Friedman; Samuel J Asirvatham
Journal:  Cardiol Clin       Date:  2014-10-23       Impact factor: 2.213

4.  Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts.

Authors:  Brian J Hansen; Jichao Zhao; Thomas A Csepe; Brandon T Moore; Ning Li; Laura A Jayne; Anuradha Kalyanasundaram; Praise Lim; Anna Bratasz; Kimerly A Powell; Orlando P Simonetti; Robert S D Higgins; Ahmet Kilic; Peter J Mohler; Paul M L Janssen; Raul Weiss; John D Hummel; Vadim V Fedorov
Journal:  Eur Heart J       Date:  2015-06-08       Impact factor: 29.983

5.  Comparison of preexisting and ablation-induced late gadolinium enhancement on left atrial magnetic resonance imaging.

Authors:  Kotaro Fukumoto; Mohammadali Habibi; Esra Gucuk Ipek; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; David D Spragg; Hiroshi Ashikaga; John Rickard; Joseph E Marine; Ronald D Berger; Hugh Calkins; Saman Nazarian
Journal:  Heart Rhythm       Date:  2014-12-19       Impact factor: 6.343

6.  Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.

Authors:  Yoshio Takemoto; Rafael J Ramirez; Kuljeet Kaur; Oscar Salvador-Montañés; Daniela Ponce-Balbuena; Roberto Ramos-Mondragón; Steven R Ennis; Guadalupe Guerrero-Serna; Omer Berenfeld; José Jalife
Journal:  J Am Coll Cardiol       Date:  2017-12-12       Impact factor: 24.094

7.  Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.

Authors:  Aaron Kunamalla; Jason Ng; Vamsi Parini; Shin Yoo; Kate A McGee; Todd T Tomson; David Gordon; Edward B Thorp; Jon Lomasney; Qiang Zhang; Sanjiv Shah; Suzanne Browne; Bradley P Knight; Rod Passman; Jeffrey J Goldberger; Gary Aistrup; Rishi Arora
Journal:  Circ Res       Date:  2016-05-23       Impact factor: 17.367

8.  The Importance of Atrial Fibrillation's Associated Comorbidities as Clinical Presentation and Outcome Contributors.

Authors:  James A Reiffel
Journal:  J Atr Fibrillation       Date:  2021-08-31

Review 9.  Left Atrial Myopathy in Atrial Fibrillation and Heart Failure: Clinical Implications, Mechanisms, and Therapeutic Targets.

Authors:  Graham Peigh; Sanjiv J Shah; Ravi B Patel
Journal:  Curr Heart Fail Rep       Date:  2021-04-17

10.  EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  J Arrhythm       Date:  2016-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.